New Breast Cancer Drug May Reduce Risk of Disease Progression or Death by 50%

June 8, 2022 by Alexa Hornbeck
New Breast Cancer Drug May Reduce Risk of Disease Progression or Death by 50%
A woman receives a mammogram for breast cancer screening. (Heather Charles/Chicago Tribune/TNS)

A study published on June 5 in The New England Journal of Medicine shows that a drug called Enhertu can lower the risk of disease progression and death from low metastatic breast cancer by 50%. 

The drug is an antibody-chemotherapy combination distributed through an IV, and is able to block a protein known as HER2 on cancer cells, and can also attack the cancer inside of the cells to slow cancer progression.

press release from the manufacturers of the drug, AstraZeneca and Daiichi Sankyo, indicates that the drug targets a protein that drives breast cancer growth and can decrease the chances of tumors. 


The study findings show that patients who received the drug had their cancer progression slowed and improved survival when compared with those who received standard chemotherapy. 


The U.S. Food and Drug Administration previously provided a breakthrough status designation for the drug to be used to treat HER2-positive breast cancer in April 2022. 


On Sunday the findings from the study were presented at an annual meeting held by the American Society of Clinical Oncology. 

Alexa can be reached at [email protected]

A+
a-

In The News

U.S. Senate
Political News
Political News

Health

Voting

Health

September 27, 2022
by TWN Staff
Study Confirms Link Between COVID Shot and Increased Menstrual Cycle Length

WASHINGTON — A new study has confirmed the findings of earlier research that linked COVID-19 vaccination with an average increase... Read More

WASHINGTON — A new study has confirmed the findings of earlier research that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The study, which was funded by the National Institutes of Health, included data from nearly 20,000 people... Read More

September 27, 2022
by TWN Staff
New York City to Abide by Judge’s Ruling on Vaccine Mandate — For Now

NEW YORK — The city of New York will abide by a judge’s order barring enforcement of its COVID-19 vaccine... Read More

NEW YORK — The city of New York will abide by a judge’s order barring enforcement of its COVID-19 vaccine mandate for members of its largest police union while the decision is being appealed. On Friday, Manhattan State Supreme Court Judge Lyle Frank ruled the city... Read More

Biogen Pays $900M to Settle Doctor Kickback Allegations

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying... Read More

BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said. The agreement announced Monday settles a whistleblower lawsuit brought by former... Read More

Teen Interest in Long-Lasting Birth Control Soars After Roe

Sixteen-year-old Adismarys Abreu had been discussing a long-lasting birth control implant with her mother for about a year as a... Read More

Sixteen-year-old Adismarys Abreu had been discussing a long-lasting birth control implant with her mother for about a year as a potential solution to increasing menstrual pain. Then Roe v. Wade was overturned, and Abreu joined the throng of teens rushing to their doctors as states began... Read More

September 26, 2022
by Dan McCue
Harvard Report Provides Tips on Bullying Chronic Inflammation

BOSTON — A new report from Harvard Medical School offers practical advice on how to deal with chronic, low-grade inflammation,... Read More

BOSTON — A new report from Harvard Medical School offers practical advice on how to deal with chronic, low-grade inflammation, an ailment that contributes to the development of cancer, cardiovascular disease and other life-threatening conditions. Currently, about three out of five people around the world die... Read More

September 26, 2022
by TWN Staff
Prenatal Steroid Treatment May Improve Survival for Extremely Preterm Infants

WASHINGTON — Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a... Read More

WASHINGTON — Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a study funded by the National Institutes of Health.  Antenatal steroid therapy, given to women at risk of preterm delivery, causes the fetal lungs to mature and... Read More

News From The Well
scroll top